Browse by Title

Type here to filter the list

P
Papillary RCC
Favorite

Manuela Schmidinger, MD – Medical University of Vienna, Austria ### 1834918###Speaker###Program Director Kidney Cancer###Medical University of Vienna, Austria###
Speaker: Manuela Schmidinger, MD – Medical University of Vienna, Austria
###
Patient-derived organotypic cultures predict immunotherapy responses
Favorite

Marieta Toma, MD (she/her/hers) – Institute of Pathology, University Hospital Bonn ### 1853284###Speaker###Deputy Director###Institute of Pathology, University Hospital Bonn###
Speaker: Marieta Toma, MD (she/her/hers) – Institute of Pathology, University Hospital Bonn
### she/her/hers
Patients trust in care
Favorite

Dena Battle – KCCure ### 1828456###Speaker###President###KCCure###
Speaker: Dena Battle – KCCure
###
Pfizer Young Investigators Session
Favorite

Lauren Meehan Machos, MPH – Pfizer ### 1900480###Speaker###Global/US Opinion Leader Liaison###Pfizer###
Speaker: Lauren Meehan Machos, MPH – Pfizer
###
Phase II study of nivolumab and salvage nivolumab + ipilimumab in RCC (HCRN GU16-260): Correlative Results
Favorite

Michael B. Atkins, MD (he/him/his) – Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA. ### 1777872###Speaker###Vice Chair of Department of Medical Oncology###Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.###
Speaker: Michael B. Atkins, MD (he/him/his) – Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
### he/him/his
Prognostication in RCC
Favorite

Daniel Heng, BSc MD MPH FRCPC MSC – Tom Baker Cancer Centr ### 1828465###Speaker###Division Head Medical Oncology & Medical Oncologist###Tom Baker Cancer Centr###
Speaker: Daniel Heng, BSc MD MPH FRCPC MSC – Tom Baker Cancer Centr
###